📣 VC round data is live. Check it out!

Yatsen Group Valuation Multiples

Discover Yatsen Group's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Aspirasi Hidup Indonesia, Byggmax Group, Azkoyen, Card Factory and more.

Yatsen Group Overview

About Yatsen Group

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.


Founded

2016

HQ

China

Employees

1.8K

Financials (LTM)

Revenue: $687M
EBITDA: ($2M)

EV

$220M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Yatsen Group Financials

Yatsen Group reported last 12-month revenue of $687M and negative EBITDA of ($2M).

In the same LTM period, Yatsen Group generated $540M in gross profit, ($2M) in EBITDA losses, and $2M in net income.

Revenue (LTM)


Yatsen Group P&L

In the most recent fiscal year, Yatsen Group reported revenue of $635M and EBITDA of ($6M).

Yatsen Group is unprofitable as of last fiscal year, with gross margin of 78%, EBITDA margin of (1%), and net margin of (2%).

See analyst estimates for Yatsen Group
LTMLast FY202320242025202620272028
Revenue$687M$635M$505M$502M$635M
Gross Profit$540M$497M$371M$387M$497M
Gross Margin79%78%74%77%78%
EBITDA($2M)($6M)($53M)($30M)($6M)
EBITDA Margin(0%)(1%)(10%)(6%)(1%)
EBIT Margin(3%)(4%)(16%)(12%)(4%)
Net Profit$2M($12M)($111M)($105M)($12M)
Net Margin0%(2%)(22%)(21%)(2%)

Financial data powered by Morningstar, Inc.

Yatsen Group Stock Performance

Yatsen Group has current market cap of $326M, and enterprise value of $220M.

Market Cap Evolution


Yatsen Group's stock price is $3.47.

Yatsen Group share price increased by 10.2% in the last 30 days, and decreased by 64.0% in the last year.

Yatsen Group has an EPS (earnings per share) of $-0.13.

See more trading valuation data for Yatsen Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$220M$326M10.2%10.2%12.7%-64.0%$-0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Yatsen Group Valuation Multiples

Yatsen Group trades at 0.3x EV/Revenue multiple, and (112.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for Yatsen Group

EV / Revenue (LTM)


Yatsen Group Financial Valuation Multiples

As of June 2, 2026, Yatsen Group has market cap of $326M and EV of $220M.

Yatsen Group has a P/E ratio of 143.5x.

LTMLast FY202320242025202620272028
EV/Revenue0.3x0.3x0.4x0.4x0.3x
EV/EBITDA(112.0x)(37.5x)(4.2x)(7.4x)(37.5x)
EV/EBIT(12.3x)(8.2x)(2.7x)(3.5x)(8.0x)
EV/Gross Profit0.4x0.4x0.6x0.6x0.4x
P/E143.5x(27.7x)(2.9x)(3.1x)(27.2x)
EV/FCF-(10.8x)(9.8x)(5.0x)(10.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Yatsen Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Yatsen Group Margins & Growth Rates

Yatsen Group grew revenue by 22% but EBITDA decreased by 300% in the last fiscal year.

In the most recent fiscal year, Yatsen Group reported gross margin of 78%, EBITDA margin of (1%), and net margin of (2%).

See estimated margins and future growth rates for Yatsen Group

Yatsen Group Margins

Last FY202420252026202720282029
Gross Margin78%77%78%79%
EBITDA Margin(1%)(6%)(1%)2%
EBIT Margin(4%)(12%)(4%)(1%)
Net Margin(2%)(21%)(2%)3%
FCF Margin(3%)(9%)(3%)-

Yatsen Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth22%(1%)27%22%
Gross Profit Growth23%4%28%23%
EBITDA Growth(300%)(43%)(80%)(300%)
EBIT Growth(80%)(25%)(56%)(80%)
Net Profit Growth(285%)(5%)(89%)(281%)
FCF Growth-99%(54%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Yatsen Group Operational KPIs

Yatsen Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.

Yatsen Group's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Yatsen Group's Rule of X is 56% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Yatsen Group
LTMLast FY202320242025202620272028
Rule of 4017%23%---
Bessemer Rule of X43%56%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue-66%65%67%66%
G&A Expenses to Revenue-7%15%13%7%
R&D Expenses to Revenue3%3%3%3%3%
Opex to Revenue-83%90%90%83%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Yatsen Group Competitors

Yatsen Group competitors include Aspirasi Hidup Indonesia, Byggmax Group, Azkoyen, Card Factory, Tricot, Hanssem, Rajesh Exports, Bourrelier Group, Victorian Plumbing Group and Vertu Motors.

Most Yatsen Group public comparables operate across Specialty Stores.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aspirasi Hidup Indonesia0.5x0.5x2.9x4.8x
Byggmax Group0.8x0.8x5.1x5.1x
Azkoyen1.3x1.3x7.3x7.0x
Card Factory0.7x0.7x3.4x3.4x
Tricot1.5x-7.5x-
Hanssem0.2x0.2x3.2x5.1x
Rajesh Exports0.0x-3.5x-
Bourrelier Group1.0x-6.2x-

This data is available for Pro users. Sign up to see all Yatsen Group competitors and their valuation data.

Start Free Trial

Yatsen Group VC Funding History

Before going public, Yatsen Group raised $255M in total equity funding, across 3 rounds.

Last private valuation of Yatsen Group was $2B, after raising $240M in March 2020 from Boyu Capital, HOPU Investment Management Company, Loyal Valley Capital, and 4 other investors.


Yatsen Group Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Mar-20Series DBoyu Capital; HOPU Investment Management Company; Loyal Valley Capital; Carlyle Group; Tiger Global; Warburg Pincus; ZhenFund$240M$2BYatsen Holding Limited, the parent company of Chinese cosmetics brands like Perfect Diary, secured $100 million in funding on March 30, 2020, from investors including Tiger Global Management, HOPU Jinghua Investment Consultancy, and Boyu Capital, at a post-money valuation of $2,000 million. The funding supported the company's growth in the competitive Chinese beauty market, where it positioned itself as a leading player in color cosmetics and skincare. The company went public on the NYSE on November 19, 2020, raising approximately $617 million, reflecting strong investor interest post-funding. Tiger Global began building its position in Yatsen in Q4 2020 ahead of the IPO. Later developments include a $120 million strategic investment from Trustar Capital in convertible notes and warrants, used for R&D, global expansion, and M&A, with 2025 net revenues reported at RMB 4.30 billion. Yatsen has launched and acquired brands like Little Ondine, Pink Bear, Galénic, DR.WU, and Eve Lom, aiming for global beauty innovation leadership.
Sep-18Series BGaorong Capital; ZhenFund$11M$100MYatsen Group, parent of Perfect Diary, is a Chinese beauty company founded in 2016 by Sun Yat-sen University graduates including CEO Huang Jinfeng. It operates digitally native direct-to-consumer brands like Perfect Diary, Little Ondine, and Abby’s Choice, primarily selling via Tmall and platforms such as WeChat, Douyin, Kuaishou, Bilibili, and RED. In May 2018, Gaorong Capital led Yatsen Group's Series A funding round at a $100 million valuation, with participation from ZhenFund. This round marked early validation for the fast-growing beauty startup, which had already ranked #1 among domestic Chinese beauty brands on Singles Day by that time. Yatsen demonstrated rapid growth post-round, achieving unicorn status with a $1 billion valuation by September 2019. The company expanded offline with over 200 experience stores across 90+ cities by 2020 and later pursued international acquisitions like Galénic, Eve Lom, and DR.WU using IPO proceeds.
Oct-17Series BHony Capital; ZhenFund$4M--

Acquisitions by Yatsen Group

Yatsen Group has acquired 2 companies to date.

Last acquisition by Yatsen Group was on March 2nd 2021. Yatsen Group acquired Evelom for $200M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Yatsen Group

Evelom
Little Ondine
Description
-
Little Ondine is a Guangzhou-headquartered brand of water-based color nail polishes offering non-toxic, peel-off formulas in shades like pastel pinks, ocean blues, and metallic golds. Products apply without base coat, dry in 60 seconds, and peel off in 5 minutes, packaged in 8 ml bottles for retail in China via Tmall and Douyin. Collections include seasonal themes with glitter and matte finishes. Launched in 2020, the brand appeals to children and sensitive skin users.
HQ CountryHong KongChina
HQ City
-
Shanghai
Deal Date2 Mar 202130 Apr 2020
Valuation$200M$7M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Yatsen Group acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Yatsen Group

Yatsen Group has invested in 1 company to date.

Latest investment by Yatsen Group was on September 9th 2021. Yatsen Group invested in MingMed in their $50M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Yatsen Group

MingMed
Description
MingMed is a Shanghai-headquartered clinical-stage biopharmaceutical company focused on biologic therapeutics for ophthalmology and oncology indications. Its lead asset GC012, a fusion protein antibody inhibiting IL-4R alpha, advances through Phase 2 clinical trials targeting diabetic retinopathy and diabetic macular edema. Simlukafusp alfa, combining CD73 blockade with PD-L1 antagonism, progresses in Phase 1/2 studies for solid tumors including non-small cell lung cancer. The broader pipeline encompasses recombinant botulinum toxin formulations, tumor immunology modulators, veterinary immunology products, and multiple first-in-class candidates at various clinical stages. Established in 2016, MingMed pursues global development partnerships.
HQ CountryChina
HQ City
Guangzhou
Deal Date9 Sep 2021
RoundSeries A
Raised$50M
InvestorsFlower City Ventures; Gaorong Capital; JCP Capital; LYFE Capital; Oceanpine Capital; Yatsen Group; Yifeng Capital
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Yatsen Group investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Yatsen Group

When was Yatsen Group founded?Yatsen Group was founded in 2016.
Where is Yatsen Group headquartered?Yatsen Group is headquartered in China.
How many employees does Yatsen Group have?As of today, Yatsen Group has over 1K employees.
Who is the CEO of Yatsen Group?Yatsen Group's CEO is Jinfeng Huang.
Is Yatsen Group publicly listed?Yes, Yatsen Group is a public company listed on NYSE.
What is the stock symbol of Yatsen Group?Yatsen Group trades under YSG ticker.
When did Yatsen Group go public?Yatsen Group went public in 2020.
Who are competitors of Yatsen Group?Yatsen Group main competitors include Aspirasi Hidup Indonesia, Byggmax Group, Azkoyen, Card Factory, Tricot, Hanssem, Rajesh Exports, Bourrelier Group, Victorian Plumbing Group, Vertu Motors.
What is the current market cap of Yatsen Group?Yatsen Group's current market cap is $326M.
What is the current revenue of Yatsen Group?Yatsen Group's last 12 months revenue is $687M.
What is the current revenue growth of Yatsen Group?Yatsen Group revenue growth (NTM/LTM) is 17%.
What is the current EV/Revenue multiple of Yatsen Group?Current revenue multiple of Yatsen Group is 0.3x.
Is Yatsen Group profitable?No, Yatsen Group is not profitable.
What is the current EBITDA of Yatsen Group?Yatsen Group has negative EBITDA and is not profitable.
What is Yatsen Group's EBITDA margin?Yatsen Group's last 12 months EBITDA margin is (0%).
What is the current EV/EBITDA multiple of Yatsen Group?Current EBITDA multiple of Yatsen Group is (112.0x).
How many companies Yatsen Group has acquired to date?As of June 2026, Yatsen Group has acquired 2 companies.
What was the largest acquisition by Yatsen Group?$200M acquisition of Evelom on 2nd March 2021 was the largest M&A Yatsen Group has done to date.
What companies Yatsen Group acquired?Yatsen Group acquired Evelom and Little Ondine.
In how many companies Yatsen Group has invested to date?As of June 2026, Yatsen Group has invested in 1 company.
What was the last Yatsen Group investment?On 9th September 2021 Yatsen Group invested in MingMed, participating in a $50M Series A round, alongside Flower City Ventures, Gaorong Capital, JCP Capital, LYFE Capital, Oceanpine Capital, and Yifeng Capital.
In what companies Yatsen Group invested in?Yatsen Group invested in MingMed.

See public comps similar to Yatsen Group

Lists including Yatsen Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial